[1] Lee WM. Recent developments in acute liver failure. Best Pract Res Clin Gastroenterol,2012,26(1):3-16. [2] Wlodzimirow KA,Eslami S,Chamuleau RA,et al. Prediction of poor outcome in patients with acute liver failure-systematic review of prediction models. PLoS One,2012,7(12):e50952. [3] Rolando N,Wade J,Davalos M,et al. The systemic inflammatory response syndrome in acute liver failure . Hepatology,2000,32(4 Pt 1):734-739. [4] Bernal W,Auzinger G,Dhawan A,et al. Acute liver failure. Lancet,2010,376(9736):190-201. [5] Rutherford AE,Hynan LS,Borges CB,et al. Serum apoptosis markers in acute liver failure:a pilot study. Clin Gastroenterol Hepatol,2007,5(12):1477-1483. [6] Wlodzimirow KA,Eslami S,Abu-Hanna A,et al. Systematic review:acute liver failure-one disease,more than 40 definitions. Aliment Pharmacol Ther,2012,35(11):1245-1256. [7] 中华医学会感染病学分会肝衰竭与人工肝学组和肝病学分会重型肝病与人工肝学组.肝衰竭诊疗指南. 实用肝脏病杂志,2006,9:321-324. [8] Liu Q,Liu Z,Wang T,et al. Characteristics of acute and sub-acute liver failure in China:nomination,classification and interval. J Gastroenterol Hepatol,2007,22(12):2101-2106. [9] Li J,Zhu X,Liu F,et al. Cytokine and autoantibody patterns in acute liver failure. J Immunotoxicol, 2010,7(3):157-164. [10] Berry PA,Antoniades CG,Hussain MJ,et al. Admission levels and early changes in serum interleukin-10 are predictive of poor outcome in acute liver failure and decompensated cirrhosis. Liver Int,2010,30(5):733-740. |